WHO ICTRP trial

Study of the role of taper graft in preventing access-associated steal syndrome…

IRCT2013041212993N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT2013041212993N1
Public title Study of the role of taper graft in preventing access-associated steal syndrome in diabetic ESRD patients
Scientific title Analysis and comparison of two types of ePTFE vascular grafts, straight 6mm vs. taper 4-6 or 4-7 mm in development of access-associated steal syndrome in diabetic patients
Primary sponsor Jondi Shpoor University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions End stage renal disease. Chronic kidney disease, stage 5;Chronic kidney disease, stage 5
Interventions Intervention 1: Intervention group: placement of taper 4-6 ePTFE arteriovenous graft as hemodialysis access. Intervention 2: Control group: placement of straight 6mm ePTFE arteriovenous graft as hemodialysis access.;Treatment…
Registration date Jul 16, 2013
Target size 40
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations